IS1622B - Úðamyndunaraðferð og -búnaður til inntöku lyfja með innöndun - Google Patents

Úðamyndunaraðferð og -búnaður til inntöku lyfja með innöndun

Info

Publication number
IS1622B
IS1622B IS3974A IS3974A IS1622B IS 1622 B IS1622 B IS 1622B IS 3974 A IS3974 A IS 3974A IS 3974 A IS3974 A IS 3974A IS 1622 B IS1622 B IS 1622B
Authority
IS
Iceland
Prior art keywords
equipment
aerosol inhaler
inhaler
aerosol
inhaler method
Prior art date
Application number
IS3974A
Other languages
English (en)
Other versions
IS3974A (is
Inventor
John Neale Philip
James Taylor Anthony
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of IS3974A publication Critical patent/IS3974A/is
Publication of IS1622B publication Critical patent/IS1622B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS3974A 1992-02-06 1993-02-05 Úðamyndunaraðferð og -búnaður til inntöku lyfja með innöndun IS1622B (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929202519A GB9202519D0 (en) 1992-02-06 1992-02-06 Medicaments

Publications (2)

Publication Number Publication Date
IS3974A IS3974A (is) 1993-08-07
IS1622B true IS1622B (is) 1996-10-18

Family

ID=10709929

Family Applications (1)

Application Number Title Priority Date Filing Date
IS3974A IS1622B (is) 1992-02-06 1993-02-05 Úðamyndunaraðferð og -búnaður til inntöku lyfja með innöndun

Country Status (31)

Country Link
US (2) US5695744A (is)
EP (1) EP0625046B1 (is)
JP (1) JP3675474B2 (is)
CN (1) CN1048394C (is)
AP (1) AP419A (is)
AT (1) ATE157875T1 (is)
AU (1) AU667074B2 (is)
BG (1) BG61862B1 (is)
CA (1) CA2128688A1 (is)
CZ (1) CZ281942B6 (is)
DE (1) DE69313825T2 (is)
DK (1) DK0625046T3 (is)
ES (1) ES2106360T3 (is)
GB (1) GB9202519D0 (is)
GE (1) GEP19991820B (is)
GR (1) GR3025363T3 (is)
HK (1) HK1009588A1 (is)
HU (2) HUT68986A (is)
IL (1) IL104628A (is)
IS (1) IS1622B (is)
MX (1) MX9300620A (is)
MY (1) MY108748A (is)
NO (1) NO306453B1 (is)
NZ (1) NZ246889A (is)
OA (1) OA10091A (is)
RO (1) RO118173B1 (is)
RU (1) RU2120285C1 (is)
SK (1) SK279291B6 (is)
TW (1) TW299234B (is)
WO (1) WO1993015741A1 (is)
ZA (1) ZA93800B (is)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919435A (en) * 1990-11-09 1999-07-06 Glaxo Group Limited Aerosol formulation containing a particulate medicament
CA2125666C (en) 1991-12-12 2002-07-16 Rachel Ann Akehurst Medicaments
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
ATE150296T1 (de) 1991-12-18 1997-04-15 Minnesota Mining & Mfg Aerosolzusammensetzungen für arzneimittelsuspensionen
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US5833950A (en) * 1992-07-31 1998-11-10 Glaxo Group Limited Aerosol formulations containing beclomethasone dipropionate-1, 1, 1, 2-tetrafluoroethane solvate
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
BR9510510A (pt) * 1994-12-22 1998-07-07 Astra Ab Formulação em aerossol farmacêutica uso da mesma e processos para fabricação da mesma para tratamento de um paciente carente de terapia
US6013245A (en) * 1995-01-26 2000-01-11 Glaxo Group Limited Aerosol formulation containing beclomethasone dipropionate and 1,1,1,2,3,3,3-heptafluoro-n-propane as propellant
US5874481A (en) * 1995-06-07 1999-02-23 Alliance Pharmaceutical Corp. Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
DK0835098T3 (da) 1995-06-27 2002-10-07 Boehringer Ingelheim Pharma Stabilt lægemiddelpræparat til frembringlese af drivgasfrie aerosoler
CZ297098B6 (cs) * 1997-01-14 2006-09-13 Lts Lohmann Therapie-Systeme Gmbh Prípravek pro kontrolované uvolnování úcinných látek v gastrointestinálním traktu a zpusob jeho výroby
US6054487A (en) * 1997-03-18 2000-04-25 Basf Aktiengesellschaft Methods and compositions for modulating responsiveness to corticosteroids
CA2282845A1 (en) * 1997-03-18 1998-09-24 Basf Aktiengesellschaft Methods and compositions for modulating responsiveness to corticosteroids
US5891420A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation
US5891419A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
US6129905A (en) * 1997-04-21 2000-10-10 Aeropharm Technology, Inc. Aerosol formulations containing a sugar as a dispersant
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6946117B1 (en) * 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6458338B1 (en) 1998-09-22 2002-10-01 Aeropharm Technology Incorporated Amino acid stabilized medicinal aerosol formulations
US6136294C1 (en) * 1998-09-22 2002-09-24 Aeropharm Technology Inc Amino acid stabilized medical aerosol formulation
IT1303692B1 (it) * 1998-11-03 2001-02-23 Chiesi Farma Spa Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione.
US6261539B1 (en) * 1998-12-10 2001-07-17 Akwete Adjei Medicinal aerosol formulation
US7074388B2 (en) * 1998-12-10 2006-07-11 Kos Life Science, Inc. Water stabilized medicinal aerosol formulation
US20060171899A1 (en) * 1998-12-10 2006-08-03 Akwete Adjei Water-stabilized aerosol formulation system and method of making
US6540983B1 (en) 2000-01-25 2003-04-01 Aeropharm Technology Incorporated Medical aerosol formulation
US6540982B1 (en) * 2000-01-25 2003-04-01 Aeropharm Technology Incorporated Medical aerosol formulation
US6565833B1 (en) 2000-05-01 2003-05-20 Aeropharm Technology Incorporated Medicinal aerosol formulation
US6548049B1 (en) 2000-05-01 2003-04-15 Aeropharm Technology Incorporated Medicinal aerosol formulation
US6447750B1 (en) 2000-05-01 2002-09-10 Aeropharm Technology Incorporated Medicinal aerosol formulation
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
ES2525087T5 (es) 2000-05-10 2018-06-28 Novartis Ag Polvos basados en fosfolípidos para administración de fármacos
AU2001247123A1 (en) * 2000-07-19 2002-02-05 Aeropharm Technology, Inc. A medicinal aerosol formulation
CA2417973A1 (en) * 2000-08-04 2002-02-14 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration
US6455028B1 (en) 2001-04-23 2002-09-24 Pharmascience Ipratropium formulation for pulmonary inhalation
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US7368102B2 (en) 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides
EP1415647A1 (en) * 2002-10-23 2004-05-06 CHIESI FARMACEUTICI S.p.A. "Long-acting beta-2 agonists ultrafine formulations"
AU2007231727B2 (en) * 2002-09-03 2010-12-16 Kos Life Sciences, Inc. Water stabilized medicinal aerosol formulation
ME00420B (me) * 2003-03-20 2011-12-20 Boehringer Ingelheim Pharmaceuticals Inc Formulacija, za inhalator u kojem se odmjerava doza, u kojoj se kao propelenti koriste hidro-fluoro-alkani
US20040191176A1 (en) * 2003-03-28 2004-09-30 Kaplan Leonard W Formulations for treatment of pulmonary disorders
MXPA06002075A (es) * 2003-08-29 2006-05-19 Glaxo Group Ltd Inhalador de dosis farmaceutica medida y metodos relacionados.
AR041873A1 (es) * 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
US20050238632A1 (en) * 2004-04-23 2005-10-27 Alburty David S Propellant formulations
CA2571519C (en) * 2004-07-02 2013-05-14 Boehringer Ingelheim International Gmbh Aerosol suspension formulations containing tg 227 ea or tg 134 a as a propellant
NZ555780A (en) 2005-02-11 2010-11-26 Pulmagen Therapeutics Synergy Combination of methylxanthine compounds and steroids to treat chronic respiratory diseases
US9084799B2 (en) 2005-02-11 2015-07-21 Pulmagen Therapeutics (Synergy) Limited Inhaled combination therapy
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
JP5825757B2 (ja) 2007-02-11 2015-12-02 マップ・ファーマシューティカルズ・インコーポレイテッド 副作用プロファイルを最小限にしながら片頭痛の迅速な緩和を可能にするｄｈｅの治療上の投与方法
RU2504402C1 (ru) * 2012-11-20 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI63672C (fi) * 1980-05-19 1983-08-10 Orion Yhtymae Oy Foerfarande foer framstaellning av en blandning av beklometasondipropionat och triklorfluormetan eller diklordifluormetan
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
GB2107715B (en) * 1981-10-19 1985-11-13 Glaxo Group Ltd Micronised beclomethasone dipropionate monohydrate and powder inhalation compositions containing it
GB8432063D0 (en) * 1984-12-19 1985-01-30 Riker Laboratories Inc Physically modified steroids
JP2769925B2 (ja) * 1990-10-18 1998-06-25 ミネソタ マイニング アンド マニュファクチャリング カンパニー ベクロメタゾン１７，２１ジプロピオネートを含んで成るエアロゾル製剤

Also Published As

Publication number Publication date
DE69313825D1 (de) 1997-10-16
SK279291B6 (sk) 1998-09-09
DE69313825T2 (de) 1998-02-05
JP3675474B2 (ja) 2005-07-27
CZ281942B6 (cs) 1997-04-16
SK92494A3 (en) 1995-04-12
EP0625046B1 (en) 1997-09-10
ES2106360T3 (es) 1997-11-01
MY108748A (en) 1996-11-30
RU2120285C1 (ru) 1998-10-20
GR3025363T3 (en) 1998-02-27
NO942923L (no) 1994-08-05
NZ246889A (en) 1996-11-26
AP9300484A0 (en) 1993-04-30
BG61862B1 (bg) 1998-08-31
OA10091A (en) 1996-12-18
NO306453B1 (no) 1999-11-08
AU667074B2 (en) 1996-03-07
IL104628A0 (en) 1993-06-10
GB9202519D0 (en) 1992-03-25
BG98897A (bg) 1995-02-28
CA2128688A1 (en) 1993-08-19
JPH07503476A (ja) 1995-04-13
IS3974A (is) 1993-08-07
CN1048394C (zh) 2000-01-19
CZ184694A3 (en) 1995-03-15
WO1993015741A1 (en) 1993-08-19
US5695744A (en) 1997-12-09
HU211696A9 (en) 1995-12-28
NO942923D0 (is) 1994-08-05
IL104628A (en) 1998-12-27
MX9300620A (es) 1993-08-01
HU9402301D0 (en) 1994-10-28
DK0625046T3 (da) 1998-04-27
RO118173B1 (ro) 2003-03-28
AU3452593A (en) 1993-09-03
HK1009588A1 (en) 1999-06-04
HUT68986A (en) 1995-08-28
EP0625046A1 (en) 1994-11-23
US5688782A (en) 1997-11-18
GEP19991820B (en) 1999-11-05
ATE157875T1 (de) 1997-09-15
AP419A (en) 1995-10-24
CN1078633A (zh) 1993-11-24
TW299234B (is) 1997-03-01
ZA93800B (en) 1993-10-06

Similar Documents

Publication Publication Date Title
IS1622B (is) Úðamyndunaraðferð og -búnaður til inntöku lyfja með innöndun
DE69401534D1 (de) Atemschutzausrüstung
EP0589554A3 (en) Airborne measurement method and device.
DE69326990D1 (de) Kodierungssystem und -verfahren
ITMI930369A0 (it) Metodo ed apparecchio per disagglomerare polveri
NO20002846D0 (no) Inhaleringsanordning og fremgangsmÕte ved samme
KR950702360A (ko) 주파수 선택 방법 및 장치(Frequency Selection Method and Apparatus)
DE69333394D1 (de) Hochwirksames Kodierverfahren und -gerät
DK0596122T3 (da) Fremgangsmåde til omvikling og omviklet genstand
GB2272651B (en) Gas trap apparatus
EP0586118A3 (en) Aerosol sampler
DE69319811D1 (de) Editiermethode und Editiergeräte
DE69429972D1 (de) Druckgerät und -verfahren
DK0774995T3 (da) Fremgangsmåde og udstyr til brandbekæmpelse
FI935648A0 (fi) Kryogenisk luftsepareringsmetod och -apparat
NO932199D0 (no) Trykkeprosess og -apparatur
FI953099A0 (fi) Laitteisto palontorjuntaa varten
ITMI940278A0 (it) Metodo e apparecchiatura per essiccare sanse
FI93778C (fi) Laser-paikannusmenetelmä ja -laitteisto
FI893775A0 (fi) Päällystyslaitteisto ja -menetelmä
FI940440A0 (fi) Palosuojausmenetelmä ja -laite
IL101253A0 (en) Method and devices for building construction
IL102124A0 (en) Method and apparatus for building construction and building constructed thereby
ITPR920013A1 (it) Metodo per circoscrivere un incendio boschivo e dispositivi per attuare detto metodo
FI951758A0 (fi) Menetelmä ja laitteisto palon torjumiseksi